KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
73 hedge funds and large institutions have $493M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 76 → 73 (-3)
Holders
73
Holding in Top 10
6
Calls
$615K
Puts
–
Top Buyers
| 1 | +$12.4M | |
| 2 | +$9.45M | |
| 3 | +$3.46M | |
| 4 |
BlackRock
New York
|
+$3.08M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$2.41M |
Top Sellers
| 1 | -$9.28M | |
| 2 | -$5.8M | |
| 3 | -$1.03M | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$270K |
| 5 |
Two Sigma Investments
New York
|
-$259K |